Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Marie Vercruyssen"'
Autor:
Fulvio Massaro, Fabio Andreozzi, Tom Abrassart, Julie Castiaux, Hanne Massa, Ornella Rizzo, Marie Vercruyssen
Publikováno v:
Biomedicines, Vol 12, Iss 5, p 977 (2024)
Over the past three decades, the treatment of lymphoproliferative disorders has undergone profound changes, notably due to the increasing availability of innovative therapies with the potential to redefine clinical management paradigms. A major impac
Externí odkaz:
https://doaj.org/article/e8516ff12f8e443496a629d4e617bbbd
Publikováno v:
Current opinion in oncology. 34(5)
Adult T-cell leukemia-lymphoma (ATL) is an aggressive mature T-cell malignancy that arises in approximately 5% of carriers of human T-lymphotropic virus type 1 (HTLV-1), but this risk is not random among carriers. We describe recent advance in pathog
Autor:
Wendy Delbart, Gwennaëlle Marin, Basile Stamatopoulos, Roland de Wind, Nicolas Sirtaine, Pieter Demetter, Marie Vercruyssen, Erwin Woff, Ioannis Karfis, Ghanem E. Ghanem, Patrick Flamen, Zéna Wimana
Publikováno v:
Cancers; Volume 15; Issue 8; Pages: 2332
Peptide receptor radionuclide therapy with 177Lu-DOTATATE improves the outcome of patients with somatostatin receptor (SSTR)-expressing neuroendocrine tumours. Nevertheless, stable disease has been the main response pattern observed, with some rare c
Publikováno v:
Cancers; Volume 14; Issue 4; Pages: 982
Classical Hodgkin lymphoma (HL) patients presenting a relapsed/refractory (R/R) disease are currently managed with salvage chemotherapy followed by autologous stem cell transplantation (ASCT). However, almost 25–30% of these patients fail to achiev
Publikováno v:
Clinical lymphoma, myelomaleukemia. 19
This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). This article has been retracted at the request of the authors. This is an ongoing trial yet to be completed.
Autor:
Dominique Bron, Chloé Spilleboudt, Sophie C. Golstein, Marie Vercruyssen, Alexandre de Wind, Kristoff Muylle
Publikováno v:
European Journal of Haematology. 101:415-417
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare lymphoma (
Autor:
Dominique Bron, N Cilla, Marianne Paesmans, P. Heimann, Lieveke Ameye, Marie Vercruyssen, A. de Wind, Nathalie Meuleman
An IgM monoclonal gammopathy points to a diagnosis of Waldenstrom's Macroglobulinemia. Other B lymphoproliferatives disorders should be ruled out but the limits are sometimes difficult to define. The discovery of the L265P mutation of the MYD88 gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::343a9e9593a902e79da7a8de78968f42
https://lirias.kuleuven.be/handle/20.500.12942/691042
https://lirias.kuleuven.be/handle/20.500.12942/691042
Diagnostic approach of an IgM monoclonal gammopathy : clinical relevance of the MYD88 L265P mutation
Autor:
Marie Vercruyssen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ba1754bc7d23d264c69fc84afd06126
https://doi.org/10.26226/morressier.5a54bfead462b80290b56491
https://doi.org/10.26226/morressier.5a54bfead462b80290b56491
Autor:
Myriam Remmelink, Marie Vercruyssen, Benoît Rondelet, Robert Naeije, François Kerbaul, Laurence Dewachter, Asmae Belhaj, Dean P Schraufnagel, Serge Brimioulle, Céline Dewachter
Publikováno v:
The Journal of Heart and Lung Transplantation. 34:1334-1345
Background Acute transient pulmonary hypertension may induce a state of persistent right ventricular (RV) failure. We hypothesized that this could be related to an activation of inflammatory processes and reduced by prostacyclin therapy. Methods Sixt
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:S337